MARCY MARKES: Open Payments
NPI 1962683995 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,150 in 160 payments from 22 companies in 2025. Trend: 2023 $23,786 · 2024 $19,154 · 2025 $14,150
Speaker / faculty: $6,394Food & beverage: $4,140Consulting: $2,646Travel & lodging: $880Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 44 | $4,499 |
| GENZYME CORPORATION | 21 | $3,812 |
| Grifols USA, LLC | 15 | $2,489 |
| Novartis Pharmaceuticals Corporation | 17 | $1,730 |
| Regeneron Healthcare Solutions, Inc. | 10 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $249 |
| Incyte Corporation | 2 | $159 |
| Genentech USA, Inc. | 6 | $119 |
| Lilly USA, LLC | 6 | $113 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $112 |
Products named: FASENRA, DUPIXENT, Prolastin-C Liquid, TEZSPIRE, AIRSUPRA, Xolair, EBGLYSS, NEFFY.
Industry payments across MO — which companies pay providers there.
